$PRTK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Paratek Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Paratek Pharmaceuticals, Inc.. Get notifications about new insider transactions in Paratek Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2021 | PRTK | Paratek Pharmaceut ... | Haskel William M. | CLO, General Counse ... | Sell | S | 9.70 | 7,561 | 73,342 | 357,092 | 364.7 K to 357.1 K (-2.07 %) |
| Jun 08 2021 | PRTK | Paratek Pharmaceut ... | Haskel William M. | CLO, General Counse ... | Grant | A | 0.00 | 28,636 | 0 | 364,653 | 336 K to 364.7 K (+8.52 %) |
| Jun 08 2021 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Sell | S | 9.70 | 9,978 | 96,787 | 268,940 | 278.9 K to 268.9 K (-3.58 %) |
| Jun 08 2021 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Grant | A | 0.00 | 28,636 | 0 | 278,918 | 250.3 K to 278.9 K (+11.44 %) |
| Apr 01 2021 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Grant | A | 0.00 | 303,750 | 0 | 904,309 | 600.6 K to 904.3 K (+50.58 %) |
| Apr 01 2021 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Grant | A | 0.00 | 121,500 | 0 | 250,282 | 128.8 K to 250.3 K (+94.35 %) |
| Apr 01 2021 | PRTK | Paratek Pharmaceut ... | Haskel William M. | CLO, General Counse ... | Grant | A | 0.00 | 132,750 | 0 | 336,017 | 203.3 K to 336 K (+65.31 %) |
| Apr 01 2021 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Grant | A | 0.00 | 281,250 | 0 | 827,767 | 546.5 K to 827.8 K (+51.46 %) |
| Apr 01 2021 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Grant | A | 0.00 | 177,750 | 0 | 449,023 | 271.3 K to 449 K (+65.52 %) |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 9,000 | 0 | 35,625 | 26.6 K to 35.6 K (+33.80 %) |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Grant | A | 0.00 | 9,000 | 0 | 32,250 | 23.3 K to 32.3 K (+38.71 %) |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Grant | A | 0.00 | 9,000 | 0 | 39,000 | 30 K to 39 K (+30.00 %) |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Hoffmann Rolf K | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Hoffmann Rolf K | Director | Grant | A | 0.00 | 9,000 | 0 | 44,000 | 35 K to 44 K (+25.71 %) |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Grant | A | 0.00 | 9,000 | 0 | 39,000 | 30 K to 39 K (+30.00 %) |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 9,000 | 0 | 30,000 | 21 K to 30 K (+42.86 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 6.71 | 26,415 | 177,245 | 600,559 | 627 K to 600.6 K (-4.21 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 6.95 | 18,585 | 129,166 | 626,974 | 645.6 K to 627 K (-2.88 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 6.71 | 12,855 | 86,257 | 271,273 | 284.1 K to 271.3 K (-4.52 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 6.95 | 9,045 | 62,863 | 284,128 | 293.2 K to 284.1 K (-3.09 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Haskel William M. | CLO, General Counse ... | Sell | S | 6.71 | 6,842 | 45,910 | 203,267 | 210.1 K to 203.3 K (-3.26 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Haskel William M. | CLO, General Counse ... | Sell | S | 6.95 | 4,814 | 33,457 | 210,109 | 214.9 K to 210.1 K (-2.24 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Sell | S | 6.71 | 8,760 | 58,780 | 128,782 | 137.5 K to 128.8 K (-6.37 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Sell | S | 6.95 | 6,164 | 42,840 | 137,542 | 143.7 K to 137.5 K (-4.29 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 6.71 | 26,063 | 174,883 | 546,517 | 572.6 K to 546.5 K (-4.55 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 6.95 | 18,337 | 127,442 | 572,580 | 590.9 K to 572.6 K (-3.10 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 5.93 | 20,928 | 124,103 | 645,559 | 666.5 K to 645.6 K (-3.14 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Grant | A | 0.00 | 75,000 | 0 | 666,487 | 591.5 K to 666.5 K (+12.68 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Sell | S | 5.93 | 8,357 | 49,557 | 143,706 | 152.1 K to 143.7 K (-5.50 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Grant | A | 0.00 | 21,250 | 0 | 152,063 | 130.8 K to 152.1 K (+16.24 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 5.93 | 26,250 | 155,663 | 590,917 | 617.2 K to 590.9 K (-4.25 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Grant | A | 0.00 | 75,000 | 0 | 617,167 | 542.2 K to 617.2 K (+13.83 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Haskel William M. | CLO, General Counse ... | Sell | S | 5.93 | 6,892 | 40,870 | 214,923 | 221.8 K to 214.9 K (-3.11 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Haskel William M. | CLO, General Counse ... | Grant | A | 0.00 | 23,125 | 0 | 221,815 | 198.7 K to 221.8 K (+11.64 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 5.93 | 15,000 | 88,950 | 293,173 | 308.2 K to 293.2 K (-4.87 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Grant | A | 0.00 | 37,500 | 0 | 308,173 | 270.7 K to 308.2 K (+13.85 %) |
| Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Option Exercise | M | 4.30 | 39,479 | 169,760 | 0 | |
| Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Buy | M | 4.30 | 39,479 | 169,760 | 591,487 | 552 K to 591.5 K (+7.15 %) |
| Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Option Exercise | M | 4.30 | 39,479 | 169,760 | 0 | |
| Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Option Exercise | M | 4.30 | 39,479 | 169,760 | 0 | |
| Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Buy | M | 4.30 | 39,479 | 169,760 | 591,487 | 552 K to 591.5 K (+7.15 %) |
| Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Buy | M | 4.30 | 39,479 | 169,760 | 591,487 | 552 K to 591.5 K (+7.15 %) |
| May 14 2020 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 4.75 | 4,666 | 22,164 | 198,690 | 203.4 K to 198.7 K (-2.29 %) |
| May 14 2020 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Sell | S | 4.75 | 6,198 | 29,441 | 130,813 | 137 K to 130.8 K (-4.52 %) |
| May 14 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 4.75 | 4,798 | 22,791 | 270,673 | 275.5 K to 270.7 K (-1.74 %) |
| May 14 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 4.75 | 9,595 | 45,576 | 552,008 | 561.6 K to 552 K (-1.71 %) |
| May 14 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 4.68 | 12,250 | 57,330 | 542,167 | 554.4 K to 542.2 K (-2.21 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 3.51 | 7,000 | 24,570 | 7,000 | |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Grant | A | 0.00 | 9,000 | 0 | 30,000 | 21 K to 30 K (+42.86 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Option Exercise | A | 3.51 | 7,000 | 24,570 | 7,000 | |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Grant | A | 0.00 | 9,000 | 0 | 23,250 | 14.3 K to 23.3 K (+63.16 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 3.51 | 7,000 | 24,570 | 7,000 | |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 9,000 | 0 | 26,625 | 17.6 K to 26.6 K (+51.06 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 3.51 | 7,000 | 24,570 | 7,000 | |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 9,000 | 0 | 21,000 | 12 K to 21 K (+75.00 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Option Exercise | A | 3.51 | 7,000 | 24,570 | 7,000 | |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Grant | A | 0.00 | 9,000 | 0 | 30,000 | 21 K to 30 K (+42.86 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Hoffmann Rolf K | Director | Option Exercise | A | 3.51 | 7,000 | 24,570 | 7,000 | |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Hoffmann Rolf K | Director | Grant | A | 0.00 | 9,000 | 0 | 35,000 | 26 K to 35 K (+34.62 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 135,000 | 0 | 554,417 | 419.4 K to 554.4 K (+32.19 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 45,000 | 0 | 203,356 | 158.4 K to 203.4 K (+28.42 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Grant | A | 0.00 | 45,000 | 0 | 137,011 | 92 K to 137 K (+48.91 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Grant | A | 0.00 | 144,000 | 0 | 561,603 | 417.6 K to 561.6 K (+34.48 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Grant | A | 0.00 | 67,500 | 0 | 275,471 | 208 K to 275.5 K (+32.46 %) |
| Dec 16 2019 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 3.10 | 2,864 | 8,878 | 158,356 | 161.2 K to 158.4 K (-1.78 %) |
| Dec 16 2019 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Sell | S | 3.10 | 6,278 | 19,462 | 92,011 | 98.3 K to 92 K (-6.39 %) |
| Dec 16 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 3.10 | 14,514 | 44,993 | 417,603 | 432.1 K to 417.6 K (-3.36 %) |
| Dec 16 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 3.10 | 4,401 | 13,643 | 207,971 | 212.4 K to 208 K (-2.07 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 3.82 | 5,322 | 20,330 | 212,372 | 217.7 K to 212.4 K (-2.44 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Grant | A | 0.00 | 13,000 | 0 | 217,694 | 204.7 K to 217.7 K (+6.35 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 3.82 | 7,818 | 29,865 | 432,117 | 439.9 K to 432.1 K (-1.78 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Grant | A | 0.00 | 26,000 | 0 | 439,935 | 413.9 K to 439.9 K (+6.28 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 12,000 | 0 | 161,220 | 149.2 K to 161.2 K (+8.04 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Sell | S | 3.82 | 5,049 | 19,287 | 98,289 | 103.3 K to 98.3 K (-4.89 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Grant | A | 0.00 | 12,000 | 0 | 103,338 | 91.3 K to 103.3 K (+13.14 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 28,000 | 0 | 419,417 | 391.4 K to 419.4 K (+7.15 %) |
| Oct 07 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 3.98 | 16,265 | 64,735 | 413,935 | 430.2 K to 413.9 K (-3.78 %) |
| Oct 07 2019 | PRTK | Paratek Pharmaceut ... | Brenner Randall B. | Chief Development & ... | Sell | S | 3.98 | 7,674 | 30,543 | 91,338 | 99 K to 91.3 K (-7.75 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 100,807 | 70.8 K to 100.8 K (+42.37 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | D | 0.00 | 16,250 | 0 | 70,807 | 87.1 K to 70.8 K (-18.67 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | D | 0.00 | 27,500 | 0 | 87,057 | 114.6 K to 87.1 K (-24.01 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | D | 0.00 | 37,000 | 0 | 114,557 | 151.6 K to 114.6 K (-24.41 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | D | 0.00 | 19,500 | 0 | 151,557 | 171.1 K to 151.6 K (-11.40 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 60,000 | 0 | 204,694 | 144.7 K to 204.7 K (+41.47 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 7.23 | 5,000 | 36,150 | 5,000 | |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 7,500 | 0 | 17,625 | 10.1 K to 17.6 K (+74.07 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Option Exercise | A | 7.23 | 5,000 | 36,150 | 5,000 | |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Grant | A | 0.00 | 7,500 | 0 | 14,250 | 6.8 K to 14.3 K (+111.11 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Option Exercise | A | 7.23 | 5,000 | 36,150 | 5,000 | |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Grant | A | 0.00 | 7,500 | 0 | 21,000 | 13.5 K to 21 K (+55.56 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 37,000 | 0 | 171,057 | 134.1 K to 171.1 K (+27.60 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 120,000 | 0 | 430,200 | 310.2 K to 430.2 K (+38.68 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Hoffmann Rolf K | Director | Option Exercise | A | 7.23 | 5,000 | 36,150 | 5,000 | |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Hoffmann Rolf K | Director | Grant | A | 0.00 | 7,500 | 0 | 26,000 | 18.5 K to 26 K (+40.54 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 37,000 | 0 | 149,220 | 112.2 K to 149.2 K (+32.97 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 7.23 | 5,000 | 36,150 | 5,000 | |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Grant | A | 0.00 | 7,500 | 0 | 21,000 | 13.5 K to 21 K (+55.56 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 7.23 | 5,000 | 36,150 | 5,000 | |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 7,500 | 0 | 12,000 | 4.5 K to 12 K (+166.67 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 120,000 | 0 | 391,417 | 271.4 K to 391.4 K (+44.21 %) |
| Feb 20 2019 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Sell | S | 7.14 | 3,000 | 21,420 | 4,500 | 7.5 K to 4.5 K (-40.00 %) |
| Feb 20 2019 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Sell | S | 7.14 | 3,750 | 26,775 | 6,750 | 10.5 K to 6.8 K (-35.71 %) |
| Feb 20 2019 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Sell | S | 7.14 | 3,750 | 26,775 | 6,750 | 10.5 K to 6.8 K (-35.71 %) |
| Feb 20 2019 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Sell | S | 7.14 | 3,375 | 24,098 | 10,125 | 13.5 K to 10.1 K (-25.00 %) |
| Feb 20 2019 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Sell | S | 7.14 | 3,375 | 24,098 | 10,125 | 13.5 K to 10.1 K (-25.00 %) |
| Feb 07 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 6.77 | 3,331 | 22,551 | 144,694 | 148 K to 144.7 K (-2.25 %) |
| Feb 07 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 6.77 | 2,495 | 16,891 | 134,057 | 136.6 K to 134.1 K (-1.83 %) |
| Feb 07 2019 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 6.77 | 1,331 | 9,011 | 112,220 | 113.6 K to 112.2 K (-1.17 %) |
| Feb 04 2019 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 15,000 | 0 | 113,551 | 98.6 K to 113.6 K (+15.22 %) |
| Feb 04 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 16,250 | 0 | 148,025 | 131.8 K to 148 K (+12.33 %) |
| Feb 04 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 32,500 | 0 | 310,200 | 277.7 K to 310.2 K (+11.70 %) |
| Feb 04 2019 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 35,000 | 0 | 271,417 | 236.4 K to 271.4 K (+14.80 %) |
| Feb 04 2019 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Gift | G | 0.00 | 20,050 | 0 | 236,417 | 256.5 K to 236.4 K (-7.82 %) |
| Dec 26 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Sell | S | 5.01 | 9,330 | 46,743 | 7,500 | 16.8 K to 7.5 K (-55.44 %) |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 6.76 | 8,400 | 56,784 | 256,467 | 264.9 K to 256.5 K (-3.17 %) |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 6.76 | 2,918 | 19,726 | 120,302 | 123.2 K to 120.3 K (-2.37 %) |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 6.25 | 1,000 | 6,250 | 98,551 | 99.6 K to 98.6 K (-1.00 %) |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 6.76 | 3,132 | 21,172 | 99,551 | 102.7 K to 99.6 K (-3.05 %) |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 6.27 | 6,000 | 37,620 | 277,700 | 283.7 K to 277.7 K (-2.11 %) |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 6.76 | 5,525 | 37,349 | 283,700 | 289.2 K to 283.7 K (-1.91 %) |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 6.76 | 3,733 | 25,235 | 131,775 | 135.5 K to 131.8 K (-2.75 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 8.96 | 6,300 | 56,448 | 264,867 | 271.2 K to 264.9 K (-2.32 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 8.96 | 6,300 | 56,448 | 264,867 | 271.2 K to 264.9 K (-2.32 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 14,000 | 0 | 271,167 | 257.2 K to 271.2 K (+5.44 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 14,000 | 0 | 271,167 | 257.2 K to 271.2 K (+5.44 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 8.96 | 2,784 | 24,945 | 123,220 | 126 K to 123.2 K (-2.21 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 8.96 | 2,784 | 24,945 | 123,220 | 126 K to 123.2 K (-2.21 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 6,500 | 0 | 126,004 | 119.5 K to 126 K (+5.44 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 6,500 | 0 | 126,004 | 119.5 K to 126 K (+5.44 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 8.96 | 2,231 | 19,990 | 102,683 | 104.9 K to 102.7 K (-2.13 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 8.96 | 2,231 | 19,990 | 102,683 | 104.9 K to 102.7 K (-2.13 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 6,000 | 0 | 104,914 | 98.9 K to 104.9 K (+6.07 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 6,000 | 0 | 104,914 | 98.9 K to 104.9 K (+6.07 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 8.96 | 5,200 | 46,592 | 289,225 | 294.4 K to 289.2 K (-1.77 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 8.96 | 5,200 | 46,592 | 289,225 | 294.4 K to 289.2 K (-1.77 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 13,000 | 0 | 294,425 | 281.4 K to 294.4 K (+4.62 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 13,000 | 0 | 294,425 | 281.4 K to 294.4 K (+4.62 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 8.96 | 2,659 | 23,825 | 135,508 | 138.2 K to 135.5 K (-1.92 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 8.96 | 2,659 | 23,825 | 135,508 | 138.2 K to 135.5 K (-1.92 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 6,500 | 0 | 138,167 | 131.7 K to 138.2 K (+4.94 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 6,500 | 0 | 138,167 | 131.7 K to 138.2 K (+4.94 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 9.82 | 5,860 | 57,545 | 98,914 | 104.8 K to 98.9 K (-5.59 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 25,000 | 0 | 104,774 | 79.8 K to 104.8 K (+31.34 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 17,500 | 0 | 79,774 | 62.3 K to 79.8 K (+28.10 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 9.82 | 16,313 | 160,194 | 257,167 | 273.5 K to 257.2 K (-5.96 %) |